Zobrazeno 1 - 10
of 387
pro vyhledávání: '"Ki‐Seong Eom"'
Autor:
Gi-June Min, Ye Eun Oh, Youngwoo Jeon, Tong Yoon Kim, Byung-Su Kim, Daehun Kwag, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Hee-Je Kim, Chang-Ki Min, Jong Wook Lee, Seok-Goo Cho
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionMonomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare, aggressive subtype of primary gastrointestinal T-cell lymphoma. Owing to the absence of symptoms characteristic of MEITL, diagnosis can be challenging, and the low
Externí odkaz:
https://doaj.org/article/4864b8289a084aeab1857df57eacf130
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionMyelofibrosis, which includes primary myelofibrosis (PMF) and secondary myelofibrosis (SMF), can exhibit cytopenic features associated with poor outcomes; however, the underlying mechanisms are unclear. Moreover, characterized by its aggr
Externí odkaz:
https://doaj.org/article/8538c15263374c5684f5ea07442b7c60
Autor:
Gi-June Min, Young-Woo Jeon, Tong Yoon Kim, Daehun Kwag, Byung-Su Kim, Joonyeop Lee, Jong Hyuk Lee, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Hee-Je Kim, Chang-Ki Min, Jong Wook Lee, Seok-Goo Cho
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract To clarify the role of allogeneic hematopoietic stem-cell transplantation (allo-HSCT) in the chimeric antigen receptor T-cell therapy era, we analyzed the clinical characteristics and outcomes of 52 patients treated with allo-HSCT with relap
Externí odkaz:
https://doaj.org/article/568101353413408dae23b839c241202a
Autor:
Soon Kyu Lee, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Seok Lee, Younghoon Kim, Ji Won Han, Hyun Yang, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Dong Yeup Lee, Sung Hak Lee, Jae-Ho Yoon, Pil Soo Sung
Publikováno v:
Diagnostics, Vol 14, Iss 16, p 1745 (2024)
Hepatic graft-versus-host disease (GVHD) significantly impacts morbidity and mortality among allogeneic hematopoietic stem cell transplant recipients. However, the relationship between clinical and immunopathological phenotypes and their influence on
Externí odkaz:
https://doaj.org/article/ef528628c2854609ad04f1c6aa5c1104
Autor:
Gi-June Min, Byung-Sik Cho, Daehun Kwag, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionIntensive chemotherapy (IC) can affect all geriatric assessment (GA) domains in older adults with acute myeloid leukemia (AML), but data on the effects of these changes on transplant outcomes are lacking.MethodsTherefore, we prospectively
Externí odkaz:
https://doaj.org/article/65b2e181f5394060b08b561448fa911d
Autor:
Daehun Kwag, Byung-Sik Cho, Su-Yeon Bang, Jong Hyuk Lee, Gi-June Min, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 12, Pp 1-8 (2022)
Abstract Venetoclax (VEN) combined with azacitidine (AZA) or decitabine (DEC) has been approved for older adults with acute myeloid leukemia (AML) unfit for intensive chemotherapy based on the pivotal VIALE-A trial. However, this trial only compared
Externí odkaz:
https://doaj.org/article/474caaa9b9e54019a124a502c0ba8ce5
Autor:
Sung-Soo Yoon, Zhiming LI, Keshu Zhou, Xiaoxi Zhou, Ye Guo, Huilai Zhang, Ki-Seong Eom, Seok Jin Kim, Sung Yong Oh, Sungnam Lim, Hagop Youssoufian, Vernon C Jiang, Zanchun Huang, Georgina Kilfoil, Xin Wang, Zhixiang Cao, Xiang LI, Alexander Wu, Yiyou Chen, Yuqin Song
Publikováno v:
HemaSphere, Vol 7, p e5826880 (2023)
Externí odkaz:
https://doaj.org/article/e2e40b0f31c540dcb9f5063aea33630a
Autor:
Ja Min Byun, Soo-Mee Bang, Eun-Ji Choi, Ki-Seong Eom, Chul Won Jung, Hye-seon Kim, Jiwon Park, Chul Won Choi
Publikováno v:
The Korean Journal of Internal Medicine, Vol 37, Iss 2, Pp 444-454 (2022)
Background/Aims Recent advances in the understanding of the pathophysiology of myeloproliferative neoplasms (MPN) were not paralleled with advances in treatment options; thus many questions regarding optimal MPN management remain unanswered. Here, we
Externí odkaz:
https://doaj.org/article/913028a3992b42ccb63a5f13b9f59c2c
Autor:
Youngwoo Jeon, Duk-Hwan Yang, Suk-Joong Oh, Jin-Hee Park, Jung-Ah Kim, Sung-Young Kim, Chul-Won Choi, Won-Sik Lee, In-Ho Kim, Yeung-Chul Mun, Gi June Min, Ki-Seong Eom, Seok-Goo Cho
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundA chemotherapy of rituximab, fludarabine and cyclophosphamide (R-FC) has been accepted as a promising frontline chemotherapy in selected patients with chronic lymphocytic leukemia (CLL). Although R-FC regimen is a relatively dose-dense regi
Externí odkaz:
https://doaj.org/article/9f7b900f3cdc4292a9d9e4e7c2b615a9
Autor:
Jae-Ho Yoon, Daehun Kwag, Jong-Hyuk Lee, Gi June Min, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Seok Lee
Publikováno v:
Therapeutic Advances in Hematology, Vol 14 (2023)
Background: Blinatumomab showed a higher complete remission (CR) rate and a safe bridging to allogeneic hematopoietic cell transplantation (allo-HCT) in adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (R/R BCP-ALL). O
Externí odkaz:
https://doaj.org/article/7ed03dcd39db4127b6aa9872cbfcd7a3